|
CDTX
|
Cidara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CGTX
|
Cognition Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
US
|
NASDAQ
|
|
CINC
|
CinCor Pharma, Inc.
|
US
|
NASDAQ
|
|
CING
|
Cingulate Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CLNN
|
Clene Inc.
|
US
|
NASDAQ
|
|
CLSD
|
Clearside Biomedical, Inc.
|
US
|
NASDAQ
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
CMRX
|
Chimerix, Inc.
|
US
|
NASDAQ
|
|
CNTB
|
Connect Biopharma Holdings Limited
|
US
|
NASDAQ
|
|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
COEP
|
Coeptis Therapeutics Holdings, Inc
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|